Skip to main content
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
7.32
+0.27 (3.83%)
Aug 23, 2024, 4:00 PM EDT - Market closed

Adverum Biotechnologies Revenue

In the year 2023, Adverum Biotechnologies had annual revenue of $3.60M.

Revenue (ttm)
$3.60M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
121
Market Cap
152.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.60M--
Dec 31, 2022---
Dec 31, 20217.50M--
Dec 31, 2020---
Dec 31, 2019250.00K-1.36M-84.49%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amylyx Pharmaceuticals 298.76M
908 Devices 52.69M
Fennec Pharmaceuticals 48.89M
Capricor Therapeutics 27.15M
Century Therapeutics 2.04M
Revenue Rankings

ADVM News

More News